Paul Terrill

1.7k total citations · 2 hit papers
13 papers, 1.2k citations indexed

About

Paul Terrill is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Paul Terrill has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Paul Terrill's work include Uterine Myomas and Treatments (6 papers), Endometriosis Research and Treatment (6 papers) and Gynecological conditions and treatments (4 papers). Paul Terrill is often cited by papers focused on Uterine Myomas and Treatments (6 papers), Endometriosis Research and Treatment (6 papers) and Gynecological conditions and treatments (4 papers). Paul Terrill collaborates with scholars based in Belgium, United States and France. Paul Terrill's co-authors include Elke Bestel, Ernest Loumaye, Jacques Donnez, Philippe Bouchard, Ian H. Osterloh, Michal Mára, G. Ugocsai, Т. В. Иванова, Lucian Pușcașiu and Т. Ф Татарчук and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Human Reproduction.

In The Last Decade

Paul Terrill

12 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery

2012 478 citations Jacques Donnez, Т. Ф Татарчук et al. New England Journal of Medicine profile →
Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids

2012 415 citations Jacques Donnez, Janusz Tomaszewski et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Terrill Belgium	9	1.1k	1.1k	78	54	40	13	1.2k
Elke Bestel Belgium	13	1.6k 1.5×	1.5k 1.5×	105 1.3×	74 1.4×	64 1.6×	28	1.7k
Maurizio Nicola D’Alterio Italy	19	506 0.5×	627 0.6×	129 1.7×	78 1.4×	162 4.0×	49	826
Т. В. Иванова Russia	4	438 0.4×	427 0.4×	31 0.4×	50 0.9×	12 0.3×	15	540
Federica Di Guardo Italy	14	377 0.4×	316 0.3×	170 2.2×	78 1.4×	82 2.0×	36	626
Robert Jach Poland	12	395 0.4×	186 0.2×	53 0.7×	101 1.9×	22 0.6×	34	555
Sanja Terzic Kazakhstan	13	233 0.2×	289 0.3×	109 1.4×	47 0.9×	72 1.8×	41	547
Harald Helland Norway	10	300 0.3×	244 0.2×	112 1.4×	54 1.0×	12 0.3×	14	459
Sabina Oldani Italy	12	486 0.5×	448 0.4×	91 1.2×	56 1.0×	63 1.6×	19	638
Patricia Haines United Kingdom	7	500 0.5×	588 0.6×	242 3.1×	147 2.7×	51 1.3×	12	758
Manuela Neri Italy	12	167 0.2×	160 0.2×	69 0.9×	26 0.5×	24 0.6×	39	365

Countries citing papers authored by Paul Terrill

Since Specialization

Citations

This map shows the geographic impact of Paul Terrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Terrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Terrill more than expected).

Fields of papers citing papers by Paul Terrill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Terrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Terrill. The network helps show where Paul Terrill may publish in the future.

Co-authorship network of co-authors of Paul Terrill

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Terrill. A scholar is included among the top collaborators of Paul Terrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Terrill. Paul Terrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Donnez, Jacques, Hugh S. Taylor, Elizabeth A. Stewart, et al.. (2022). Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials. The Lancet. 400(10356). 896–907. 39 indexed citations

Griesinger, Georg, Jacques Donnez, Andrew Humberstone, et al.. (2020). THE EFFECT OF THE ORAL OXYTOCIN ANTAGONIST, NOLASIBAN, ON PREGNANCY RATES IN WOMEN UNDERGOING EMBRYO TRANSFER FOLLOWING IVF. Fertility and Sterility. 114(3). e303–e303. 1 indexed citations

Griesinger, Georg, Christophe Blockeel, Piotr Pierzyński, et al.. (2020). Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials. Human Reproduction. 36(4). 1007–1020. 7 indexed citations

Taylor, Robert N., Elke Bestel, Jean‐Pierre Gotteland, et al.. (2019). Long term treatment of endometriosis associated pain (EAP) with linzagolix: efficacy and safety after 12 months of treatment. Fertility and Sterility. 112(3). e323–e323. 8 indexed citations

Humberstone, Andrew, et al.. (2019). Babies born following administration of nolasiban before embryo transfer (ET) after IVF: neonatal and infant development outcomes from a double-blind, placebo-controlled, clinical trial. Fertility and Sterility. 112(3). e7–e8.

Tournaye, Herman, et al.. (2018). A placebo-controlled, randomized, double-blind, phase 3 study assessing ongoing pregnancy rates after single oral administration of a novel oxytocin receptor antagonist, nolasiban, prior to single embryo transfer. Fertility and Sterility. 110(4). e45–e45. 3 indexed citations

Ralph, David, et al.. (2018). Efficacy and Safety of MED2005, a Topical Glyceryl Trinitrate Formulation, in the Treatment of Erectile Dysfunction: A Randomized Crossover Study. The Journal of Sexual Medicine. 15(2). 167–175. 16 indexed citations

Donnez, Jacques, Robert Hudeček, Olivier Donnez, et al.. (2014). Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertility and Sterility. 103(2). 519–527.e3. 144 indexed citations

Barlow, David H., Mary-Ann Lumsden, Bart C.J.M. Fauser, Paul Terrill, & Elke Bestel. (2014). Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo. Human Reproduction. 29(3). 480–489. 18 indexed citations

10.

Donnez, Jacques, Janusz Tomaszewski, Francisco Vega, et al.. (2013). Ulipristal Acetate Versus Leuprolide Acetate for Uterine Fibroids. Obstetrical & Gynecological Survey. 68(2). 99–100. 48 indexed citations

11.

Atkinson, Gary, Abdel Douiri, Thomas Jaki, et al.. (2013). Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert group. Pharmaceutical Statistics. 12(5). 255–259. 15 indexed citations

12.

Donnez, Jacques, Т. Ф Татарчук, Philippe Bouchard, et al.. (2012). Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery. New England Journal of Medicine. 366(5). 409–420. 478 indexed citations breakdown →

13.

Donnez, Jacques, Janusz Tomaszewski, Francisco Vega, et al.. (2012). Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids. New England Journal of Medicine. 366(5). 421–432. 415 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact